Haemodynamic effects of prenalterol in acute myocardial ischaemia in open chest pigs

Clinical and Experimental Pharmacology & Physiology
A BranziB Magnani

Abstract

The haemodynamic effects of prenalterol, a new sympathomimetic agent, have been studied in anaesthetized open-chest pigs with acute myocardial ischaemia provoked by left anterior descending coronary artery ligation. A group of eight animals was infused with saline and served as control (C). In both groups the ligation of the left anterior descending coronary artery determined a significant (P less than 0.05) reduction of aortic flow, maximum left ventricular (LV) dp/dt with no changes in heart rate. The infusion of a first dose of 30 micrograms/kg of prenalterol restored the depressed haemodynamics but increased significantly the heart rate in the prenalterol group while the saline infused group did not show any significant changes. The haemodynamic effects of prenalterol were still evident 25 min after the infusion. The subsequent administration of a second dose of 60 micrograms/kg of prenalterol resulted in a further improvement of the aortic flow, LV dp/dt and heart rate which reached values higher than in the basal condition. The positive inotropic effect was not associated with changes in stroke volume, therefore the increase in aortic flow was essentially due to an increase of the heart rate. It is concluded that prenalte...Continue Reading

References

Nov 10, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·E CarlssonB Tångstrand
May 31, 1978·European Journal of Clinical Pharmacology·G JohnssonJ Wikstrand
Apr 1, 1979·British Journal of Clinical Pharmacology·D H ScottD B Scott
May 1, 1974·Circulation Research·N W RobieJ L McNay
Feb 1, 1980·British Heart Journal·I HuttonW S Hillis
Sep 1, 1980·The Journal of Pharmacy and Pharmacology·U Johansson, B Waldeck
Sep 1, 1980·The Journal of Pharmacy and Pharmacology·A HedbergE Carlsson
Oct 1, 1980·European Journal of Clinical Pharmacology·T L SvendsenJ Trap-Jensen
Nov 1, 1980·European Journal of Clinical Pharmacology·A WeissU C Dubach
Jan 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·N RohmH J Schümann
Jul 1, 1981·Journal of Cardiovascular Pharmacology·P C KirlinB R Lucchesi

Related Concepts

Metazoa
Cardiotonic Agents
Coronary Heart Disease
Pulse Rate
Hemodynamics
Myocardial Contraction
Dalzic
Prenalterol Hydrochloride
Family suidae

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.